0000899243-22-004186.txt : 20220202
0000899243-22-004186.hdr.sgml : 20220202
20220202171545
ACCESSION NUMBER: 0000899243-22-004186
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220131
FILED AS OF DATE: 20220202
DATE AS OF CHANGE: 20220202
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Vavricka John
CENTRAL INDEX KEY: 0001829630
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39661
FILM NUMBER: 22584760
MAIL ADDRESS:
STREET 1: C/O ATEA PHARMACEUTICALS, INC.
STREET 2: 125 SUMMER STREET
CITY: BOSTON
STATE: MA
ZIP: 02110
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Atea Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001593899
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 460574869
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 125 SUMMER STREET
STREET 2: 16TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02110
BUSINESS PHONE: 857-204-8109
MAIL ADDRESS:
STREET 1: 125 SUMMER STREET
STREET 2: 16TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02110
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-01-31
0
0001593899
Atea Pharmaceuticals, Inc.
AVIR
0001829630
Vavricka John
125 SUMMER STREET
16TH FLOOR
BOSTON
MA
02110
0
1
0
0
Chief Commercial Officer
Stock Option (Right to Buy)
7.14
2022-01-31
4
A
0
135000
0.00
A
2032-01-30
Common Stock
135000
135000
D
The option vests and becomes exercisable in forty-eight (48) equal monthly installments following January 31, 2022.
/s/ Andrea Corcoran, as Attorney-in-Fact for John Vavricka, Andrea Corcoran, as Attorney-in-Fact for John Vavricka
2022-02-02